Mitochondrial function is involved in LDL oxidation mediated by human cultured endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 8, 1997, Pages 1575-1582

  Mabile, Laurence ^a   Meilhac, Olivier ^a   Escargueil Blanc, Isabelle ^a   Troly, Muriel ^a   Picraggi, Marie Thérèse ^a   Salvayre, Robert ^a   Nègre Salvayre, Anne ^a  

^a CHU RANGUEIL   (France)

Author keywords

Atherosclerosis; Human endothelial cells; LDL; Mitochondria; Oxidation; Superoxide union

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; HUMAN; HUMAN CELL; LIPID OXIDATION; MITOCHONDRION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030885625     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.8.1575     Document Type: Article

References (19)

1. Goldstein JL, Brown MS. The LDL pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897-930.
2. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223-261.
3. Stokes J. Dyslipidemia as a risk factor for cardiovascular disease and untimely death: the Framingham Study. Atheroscler Rev. 1988;18:49-57.
4. Ross R. The pathogenesis of atherosclerosis. N Engl J Med. 1986;314:488-500.
5. Haberland ME, Fogelman AM. The role of altered lipoproteins in the pathogenesis of atherosclerosis. Am Heart J. 1987;113:573-577.
6. Jürgens G, Hoff HF, Chisolm GM, Esterhauer H. Modifications of human serum LDL by oxidation: characterization and pathophysiologic implications. Chem Phys Lipids. 1987;45:315-336.
7. Steinberg D, Parthasarathy S, Carew T, Khoo JC, Witztum JL. Beyond cholesterol: modifications of LDL that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
8. Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 1990;9:155-168.
9. Witztum JL, Steinberg D. Role of oxidized LDL in atherogenesis. J Clin Invest. 1991;88:1785-1792.
10. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jürgens G. Biochemical, structural and functional properties of oxidized LDL. Chem Res Toxicol. 1990;3:77-92.
11. Haberland ME, Fong D, Cheng L. Malondialdehyde altered protein occurs in atheroma of Watanabe heritable hypcrlipidemic rabbits. Science. 1988;241:215-218.
12. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner G, Socher SS, Butler S, Parthasarathy S, Carew TE, Steinbcrg D, Witztum JL. Low density lipoprotcin undergoes oxidative modifications in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
13. Boyd HC, Gown AM, Wolfhauer G, Chait A. Direct evidence for a protein recognized by a monocional antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol. 1989;135:815-825.
14. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of LDL previously incubated with cultured endothelial cells: recognition by receptors for acetylated LDL. Proc Natl Acad Sci U S A. 1981;78:6499-6503.
15. Morel DW, DiCorlctto PE, Chisolm GM. Endothelial and smooth muscle cells alter LDL in vitro by free radical oxidation. Arteriosclerosis. 1984;4:357-364.
16. Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 1986;6:505-510.
17. Lamb DJ, Wilkins GM, Leake DS. The oxidative modification of LDL by human lymphocytes. Atherosclerosis. 1992;92:187-192.
18. Heinecke W, Baker L, Rosen H, Chait A. Superoxide-mediated modification of LDL by arterial smooth muscle cells. J Clin Invest. 1986;77:757-761.
19. Steinbrechef UP. Role of Superoxide in endothelial cell modification of low density lipoproteins. Biochim Biophys Acta. 1988;959:20-30.